Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany

M Gross, U Beckenbauer, J Burkowitz, H Walther, B Brueggenjuergen, M Gross, U Beckenbauer, J Burkowitz, H Walther, B Brueggenjuergen

Abstract

Background: Gastro-oesophageal reflux disease (GERD) is a common disorder with consequences for the patient's health-related quality of life (HRQoL). In Germany, few data are available on the impact of GERD on work-related productivity.

Aim: To study the impact of GERD on work productivity despite proton pump inhibitor (PPI) therapy and the association between productivity and symptom duration, severity, and HRQoL.

Methods: Retrospective data from randomly selected patients with chronic GERD symptoms, treated by office-based general practitioners or general internists with routine clinical care, were analyzed together with information from self-administered instruments assessing work productivity (WPAI-GERD), symptoms (RDQ), and HRQoL (QOLRAD).

Results: Reduced productivity was reported by 152 of 249 patients (61.0%), although 89.5% of them were treated with PPI. The reduction in work productivity was 18.5% in all patients and 30.3% in those with reduced productivity. Patients with impaired productivity showed a significantly lower HRQoL and more-severe symptoms of reflux disease. In all patients, the mean sick leave attributable to reflux symptoms was 0.6 hours in the previous seven days and 1.4 work days in the previous three months.

Conclusion: GERD has a substantial impact on work productivity in Germany, even in patients receiving routine clinical care and PPI therapy.

References

    1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–717. doi: 10.1136/gut.2004.051821.
    1. Willich SN, Nocon M, Kulig M, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther. 2006;23(3):371–376. doi: 10.1111/j.1365-2036.2006.02763.x.
    1. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease--an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18(8):767–776. doi: 10.1046/j.1365-2036.2003.01770.x.
    1. Nocon M, Keil T, Willich SN. Prevalence and sociodemographics of reflux symptoms in Germany--results from a national survey. Aliment Pharmacol Ther. 2006;23(11):1601–1605. doi: 10.1111/j.1365-2036.2006.02924.x.
    1. Hungin AP, Raghunath AS, Wiklund I. Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease. Fam Pract. 2005;22(6):591–603. doi: 10.1093/fampra/cmi061.
    1. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis. 2004;22(2):108–114. doi: 10.1159/000080308.
    1. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastrooesophageal reflux symptoms and health-related quality of life in the adult general population - the Kalixanda study. Aliment Pharmacol Ther. 2006;23(12):1725–1733. doi: 10.1111/j.1365-2036.2006.02952.x.
    1. Wahlqvist P, Reilly MC, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther. 2006;24(2):259–272. doi: 10.1111/j.1365-2036.2006.02996.x.
    1. Wahlqvist P, Brook RA, Campbell SM, Wallander MA, Alexander AM, Smeeding JE, Kleinman NL. Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease. J Occup Environ Med. 2008;50(1):25–31. doi: 10.1097/JOM.0b013e31815dba5a.
    1. Leodolter A, Nocon M, Kulig M, Willich SN, Malfertheiner P, Labenz J. Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort study. World J Gastroenterol. 2005;11(45):7148–7151.
    1. Liker H, Jones R, Ducrotte P. The effect of sleep disturbance due to gastroesophageal reflux diesease on work and leisure productivity: results from a multinational survey. Gastroenterology. 2005;128:A386.
    1. Meining A, Driesnack U, Classen M, Rösch T. Management of gastroesophageal reflux disease in primary care: results of a survey in 2 areas in Germany. Z Gastroenterol. 2002;40(1):15–20. doi: 10.1055/s-2002-19638.
    1. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Paré P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD) Eur J Surg Suppl. 1998;583:41–49.
    1. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I. Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Dig Dis Sci. 2001;46(3):571–580. doi: 10.1023/A:1005655317121.
    1. Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdörffer E, Miehlke S, Carlsson J, Wiklund IK. Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes. 2003;1:62. doi: 10.1186/1477-7525-1-62.
    1. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(1):52–57. doi: 10.1111/j.1572-0241.2001.03451.x.
    1. Nocon M, Kulig M, Leodolter A, Malfertheiner P, Willich SN. Validation of the Reflux Disease Questionnaire for a German population. Eur J Gastroenterol Hepatol. 2005;17(2):229–233. doi: 10.1097/00042737-200502000-00015.
    1. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi: 10.2165/00019053-199304050-00006.
    1. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastroesophageal reflux disease (WPAI-GERD)--results from a cross-sectional study. Value Health. 2002;5(2):106–113. doi: 10.1046/j.1524-4733.2002.52101.x.
    1. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001;96(8 Suppl):S57–61.
    1. Calleja JL, Bixquert M, Maldonado J. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig Dis Sci. 2007;52(10):2858–2865. doi: 10.1007/s10620-006-9196-z.
    1. Rey E, Elola-Olaso C, Rodríguez Artalejo F, Díaz-Rubio M. Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain. Rev Esp Enferm Dig. 2006;98(7):518–526.
    1. Stewart WF, Ricci JA, Leotta C. Health-related lost productive time (LPT): recall interval and bias in LPT estimates. J Occup Environ Med. 2004;46(6 Suppl):S12–22.
    1. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003;17(10):1309–1317. doi: 10.1046/j.1365-2036.2003.01588.x.
    1. Jones R, Armstrog D, Mnalfertheiner P, Ducrotté P. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin. 2006;22(4):657–662. doi: 10.1185/030079906X100032.
    1. Kirby CN, Piterman L, Nelson MR, Dent J. Gastro-oesophageal reflux disease--impact of guidelines on GP management. Aust Fam Physician. 2008;37(1-2):73–77.
    1. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10(5):460–466. doi: 10.2165/00019053-199610050-00003.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren